Skip to main content
. 2023 Apr 26;37(6):1216–1233. doi: 10.1038/s41375-023-01895-z

Table 1.

Patient characteristics of the dx cohort (n = 50).

Patient no. Patient age [months] Treatment protocol sex Time to event (last follow-up) [months] % blasts EGR3 ΔCT Mean IGHM ΔCT Mean CD79A ΔCT Mean BLK ΔCT Mean PTPN6 ΔCT Mean HOXA9ΔCT Mean
1 5.0 Interfant-06 F (40.1) 49 8.1850 3.9578 2.6439 5.1517 3.8854 13.3592
2 6.0 / F / 82 11.2758 4.1454 2.2853 4.3700 2.1229 3.9204
3 2.0 Interfant-06 F (23.6) 46 9.3618 4.8963 2.7340 4.4007 4.4306 12.9546
4 6.0 Interfant-06 M (17.1) 90 11.1637 9.1284 7.8716 9.8465 10.1343 11.5783
5 10.0 / M / 90 8.8214 5.4178 6.2042 10.2556 9.6764 3.5974
6 2.0 Interfant-06 M (83.6) 95 11.5618 6.2522 6.9626 8.1896 8.8812 4.9698
7 3.0 Interfant-06 F (5.6) 96 8.5196 5.8631 2.8374 −1.4396 2.4810 11.0093
8 3.0 Interfant-06 F (1.2) 71 8.2271 4.9521 5.1072 −0.4361 4.2495 4.9163
9 3.0 Interfant-06 M (2.5) 85 8.0114 4.5490 3.3648 −0.8208 2.8412 4.5976
10 6.0 Interfant-06 F 9.5 (10.7) 98 12.3136 8.2192 8.1777 8.7455 8.1889 5.0818
11 0.1 / F / 96 11.2989 11.8824 9.8611 10.2911 9.2719 8.6964
12 1.0 / M / 98 11.6236 11.8944 8.6850 9.7199 9.8527 12.3443
13 12.0 / F / 90 9.1826 4.9885 1.9742 3.1891 −0.3517 2.2824
14 4.0 / F / n/a 11.4695 6.3329 3.2521 4.4310 1.3435 11.4825
15 2.0 Interfant-06 M 6.0 (6.0) 90 13.3440 4.6279 2.6102 4.9218 1.1705 4.6973
16 5.5 Interfant-06 M 9.5 (15.0) 94 9.5330 9.9035 5.8136 6.3955 4.2272 6.2129
17 1.5 Interfant-06 F 10.0 (13.0) 92 6.2132 11.4431 8.3688 8.4548 6.1221 6.0703
18 3.0 Interfant-06 F 6.0 (11.5) 87 9.4723 9.2393 7.5200 8.7426 4.7647 2.0906
19 2.0 Interfant-06 F 10.5 (19) 96 7.2056 2.4819 2.0453 −1.9534 2.4821 7.8537
20 1.5 Interfant-06 M 26.5 (41.0) 96 11.2026 5.8739 4.8320 0.2568 6.2901 4.4627
21 6.5 Interfant-06 M 24.0 (32.8) 43 8.7817 6.5124 3.1900 0.3659 3.1614 11.2673
22 6.0 Interfant-06 F 19.5 (23.5) 94 10.0553 6.4983 2.9073 −1.3699 3.5784 11.5891
23 12.0 Interfant-06 F 32.0 (60.6) 92 8.0600 6.9642 4.0856 3.3604 1.6443 11.1226
24 9.0 Interfant-06 M (84.9) 93 7.0569 3.3029 1.1508 2.1274 1.1842 8.7665
25 2.0 Interfant-06 F (118.8) 93 10.2925 4.4468 1.7712 2.0883 0.4488 4.6017
26 3.0 Interfant-06 M 8.0 (108.5) 96 8.7375 7.0230 3.4687 4.0864 2.6431 13.0872
27 5.5 Interfant-06 M (9.0) 95 9.1105 5.8320 2.9365 4.0461 1.5317 5.9626
28 5.0 Interfant-06 M 17.0 (33.0) 97 5.0456 5.0784 2.0327 4.8259 1.2226 5.9922
29 2.0 Interfant-06 F 56.0 (58.6) 90 9.3271 3.7605 3.9045 2.4719 4.2582 5.3297
30 1.5 Interfant-06 F (146.1) 88 9.8910 3.3500 2.1610 0.6500 2.7175 5.8358
31 8.3 Interfant-06 F (109.3) 81 6.5075 1.0567 0.0773 −0.7910 1.6433 2.2195
32 8.2 Interfant-06 M (95.9) 92 7.2074 1.7896 2.8559 0.3826 0.8519 1.7726
33 10.7 Interfant-06 M 8.8 (8.8) 85 2.4138 -2.0719 0.3777 −0.1263 1.5011 2.6953
34 1.7 Interfant-06 F (91.5) 93 6.2540 1.4646 1.9100 1.0432 2.1243 3.8579
35 11.7 Interfant-06 F (73.2) 95 10.9273 4.7296 1.2813 3.3225 2.8393 2.9311
36 10.4 Interfant-06 F (75.9) 92 10.4144 4.0039 2.3851 3.3520 2.9626 5.7541
37 2.4 Interfant-06 F (73.8) 95 9.8438 5.2626 2.1926 4.1514 3.4033 13.3331
38 4.5 Interfant-06 M 16.1 (63.5) 87 11.4891 4.6039 1.4411 3.5708 2.5554 4.6562
39 1.1 Interfant-06 F 3.3 (15.7) 93 11.9464 6.0799 2.8532 4.2890 4.2377 12.9071
40 5.3 Interfant-06 M (58.7) 94 10.3705 4.6305 2.2531 3.8496 3.0655 5.4284
41 6.9 Interfant-06 F (63.2) 16 9.7053 5.4245 1.3355 3.4142 5.0462 9.2472
42 5.3 Interfant-06 M (60.7) 88 9.5640 3.2046 −0.1283 2.8862 1.5220 3.4737
43 0.6 Interfant-06 F 5.0 (11.9) 97 8.6364 5.2214 1.5813 3.6253 2.8227 7.9122
44 1.5 Interfant-06 M 17.3 (18.3) 98 9.5745 6.0122 0.6954 3.0358 3.6119 8.1333
45 4.4 Interfant-06 M 6.6 (10.8) 82 10.2528 4.5355 0.2110 3.4874 2.4696 4.2993
46 9.1 Interfant-06 F 39.7 (45.2) 71 9.3985 5.1434 1.5751 4.8219 2.9164 3.1663
47 0.5 Interfant-06 F 8.7 (13.3) 93 9.9358 10.9029 7.9047 7.4532 8.7790 6.2701
48 6.1 AIEOP-BFM ALL 2017 F 6.6 n/a 9.4741 11.2982 8.5621 6.0722 10.3424 12.6734
49 6.1 AIEOP-BFM ALL 2017 F 8.3 n/a 10.5529 11.9934 8.9069 9.1727 8.9088 4.5847
50 10.6 / M / n/a 5.1199 10.1187 9.3696 7.7286 11.0893 5.0774

Samples were taken from PB at the day of diagnosis. Gene expression values are indicated as the ΔCT mean of technical triplicates.

% blasts Blast percentages measured at diagnosis in PB, F female, M male.